Literature DB >> 22299588

Inhibition of the β-class carbonic anhydrases from Mycobacterium tuberculosis with carboxylic acids.

Alfonso Maresca1, Daniela Vullo, Andrea Scozzafava, Gheorghe Manole, Claudiu T Supuran.   

Abstract

The growth of Mycobacterium tuberculosis is strongly inhibited by weak acids although the mechanism by which these compounds act is not completely understood. A series of substituted benzoic acids, nipecotic acid, ortho- and para-coumaric acid, caffeic acid and ferulic acid were investigated as inhibitors of three β-class carbonic anhydrases (CAs, EC 4.2.1.1) from this pathogen, mtCA 1 (Rv1284), mtCA 2 (Rv3588c) and mtCA 3 (Rv3273). All three enzymes were inhibited with efficacies between the submicromolar to the micromolar one, depending on the scaffold present in the carboxylic acid. mtCA 3 was the isoform mostly inhibited by these compounds (K(I)s in the range of 0.11-0.97 µM); followed by mtCA 2 (K(I)s in the range of 0.59-8.10 µM), whereas against mtCA 1, these carboxylic acids showed inhibition constants in the range of 2.25-7.13 µM. This class of relatively underexplored β-CA inhibitors warrant further in vivo studies, as they may have the potential for developing antimycobacterial agents with a diverse mechanism of action compared to the clinically used drugs for which many strains exhibit multi-drug or extensive multi-drug resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22299588     DOI: 10.3109/14756366.2011.650168

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  15 in total

Review 1.  Small Molecules That Sabotage Bacterial Virulence.

Authors:  Benjamin K Johnson; Robert B Abramovitch
Journal:  Trends Pharmacol Sci       Date:  2017-02-14       Impact factor: 14.819

2.  A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.

Authors:  Murat Bozdag; Melissa Pinard; Fabrizio Carta; Emanuela Masini; Andrea Scozzafava; Robert McKenna; Claudiu T Supuran
Journal:  J Med Chem       Date:  2014-11-10       Impact factor: 7.446

3.  A class of carbonic anhydrase I - selective activators.

Authors:  Erol Licsandru; Muhammet Tanc; Istvan Kocsis; Mihail Barboiu; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-11-01       Impact factor: 5.051

Review 4.  Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.

Authors:  Ashok Aspatwar; Jean-Yves Winum; Fabrizio Carta; Claudiu T Supuran; Milka Hammaren; Mataleena Parikka; Seppo Parkkila
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

5.  Synthesis carbonic anhydrase enzyme inhibition and antioxidant activity of novel benzothiazole derivatives incorporating glycine, methionine, alanine, and phenylalanine moieties.

Authors:  Deniz Üzeroğlu Payaz; F Zehra Küçükbay; Hasan Küçükbay; Andrea Angeli; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  Ascaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis.

Authors:  Reza Zolfaghari Emameh; Marianne Kuuslahti; Daniela Vullo; Harlan R Barker; Claudiu T Supuran; Seppo Parkkila
Journal:  Parasit Vectors       Date:  2015-09-18       Impact factor: 3.876

7.  Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.

Authors:  P V Sri Ramya; Srinivas Angapelly; Andrea Angeli; Chander Singh Digwal; Mohammed Arifuddin; Bathini Nagendra Babu; Claudiu T Supuran; Ahmed Kamal
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 8.  Crystallography and Its Impact on Carbonic Anhydrase Research.

Authors:  Carrie L Lomelino; Jacob T Andring; Robert McKenna
Journal:  Int J Med Chem       Date:  2018-09-13

9.  Synthesis and biological evaluation of benzenesulphonamide-bearing 1,4,5-trisubstituted-1,2,3-triazoles possessing human carbonic anhydrase I, II, IV, and IX inhibitory activity.

Authors:  Rajiv Kumar; Vikas Sharma; Silvia Bua; Claudiu T Supuran; Pawan K Sharma
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

10.  Preparation, carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety.

Authors:  Hasan Küçükbay; Zeynep Gönül; F Zehra Küçükbay; Andrea Angeli; Gianluca Bartolucci; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.